PAB Clinical Research Studies
Currently recruiting for the following studies
Click on the study you are interested in to learn more about the trial
Upcoming Studies
Click on the study you are interested in to Request more information
Not currently being conducted or actively enrolling
- Blood Clots and Blood Clots in Lungs
- Bronchiectasis
- COPD Post Hospital
- COPD with Heart Problems
- Excessive Sleepiness Associated
with Shift Work - Gout with Kidney Impairment
- Diabetic Neuropathic Pain
- Low Testosterone
- Hepatitis B Vaccine
- High Triglycerides with Heart Risk
- Insomnia Adult & Elderly
- Insomnia for the blind
- Irritable Bowel Syndrome Primarily Diarrhea
- Hypertension
- Sleep Apnea
- GERD
- High cholesterol and heart risk
- Overactive Bladder
- Restless Leg Syndrome
- Shingles Vaccine
- Toe Fungus
- Type II Diabetes Mellitus
- Pulmonary Fibrosis
- Diabetic Peripheral Neuropathy
- High Cholesterol
Have you been diagnosed with fibromyalgia? Are you between the ages of 18-59 years?
If so, you may be interested in this clinical research study.
If so, you may be interested in this clinical research study.
Study Information:
-
Study lasts about 3 months and involves about 8 visits to site
-
Study-related costs included (laboratory tests, study visits, etc.)
-
Compensation for time and travel up to $625.00
If you or someone you know may be interested in this study, please
Contact us to learn more information.
Have you been diagnosed with narcolepsy? And are you between the ages of 18-65 years? If so, you may be interested in this clinical research study.
The primary objective is to assess the safety of an investigational medication compared to placebo in the treatment of excessive daytime sleepiness in adult subjects with narcolepsy.
The primary objective is to assess the safety of an investigational medication compared to placebo in the treatment of excessive daytime sleepiness in adult subjects with narcolepsy.
Study Information:
-
Study lasts about 17 weeks and involves up to 9 visits to site
-
Study-related costs included (laboratory tests, study visits, etc.)
-
Compensation for time and travel up to about $910.00
If you or someone you know may be interested in this study, please
Contact us to learn more information.
Do you suffer from irritable bowel syndrome with primarily diarrhea? Are you between the ages of 18-80 years? If so, you may be interested in this clinical research study.
The primary objective of this study is to evaluate the clinical response of an investigational medication compared to placebo in patients with IBS-d.
The primary objective of this study is to evaluate the clinical response of an investigational medication compared to placebo in patients with IBS-d.
Study Information:
-
Study lasts about 58 weeks and involves about 14 visits to site
-
Study-related costs included (laboratory tests, study visits, etc.)
-
Compensation for time and travel up to about $650.00
If you or someone you know may be interested in this study, please
Contact us to learn more information.
Have you been diagnosed with COPD? And are you 40 years of age or older? If so, you may be interested in this clinical research study.
The primary objective is to evaluate lung function and exercise endurance time after 12 weeks of once-daily administration of an investigational medication in patients with moderate to severe COPD.
The primary objective is to evaluate lung function and exercise endurance time after 12 weeks of once-daily administration of an investigational medication in patients with moderate to severe COPD.
Study Information:
-
Study lasts about 30 weeks and involves about 12 visits to site
-
Study-related costs included (laboratory tests, study visits, etc.)
- Compensation for time and travel
If you or someone you know may be interested in this study, please
Contact us to learn more information.
Have you been diagnosed with Gout? And are you a male at least 50 years of age / female at least 55 years of age?
If so, you may be interested in this research study.
The objective of this study is to compare the risk of predefined major heart or blood vessel events during treatment with febuxostat and allopurinol in subjects with diseases associated with gout.
The objective of this study is to compare the risk of predefined major heart or blood vessel events during treatment with febuxostat and allopurinol in subjects with diseases associated with gout.
Study Information:
- Study last approximately 5 years
- Includes visits every 3 months for first year and bi-monthly phone calls for following years
- The study drug, study-related procedures and tests, and study visits will be provided free of charge
- Compensation may be offered for time and travel
If you may be interested in this study, please Contact Us for more information.
If you have been diagnosed with Type II Diabetes, you may be eligible to participate in a clinical research study.
In order to be considered for the study, you must be:
-
Generally healthy
-
18 to 80 years of age
And you must be able to answer yes to ONE of the following:
-
Do you have type 2 diabetes mellitus not adequately controlled with diet and exercise alone?
OR
-
Do you have type 2 diabetes mellitus not adequately controlled by metformin alone?
This study includes 14 clinic visits across a 17-18 week period.
If you qualify, you will receive all study-related care and investigational study medication at no cost to you.
Compensation may be available for time and travel.
If you qualify, you will receive all study-related care and investigational study medication at no cost to you.
Compensation may be available for time and travel.
If you or someone you know may be interested in this study, please
Contact Us to learn more information.
Do you have diabetes? Do you also have history or current evidence of heart problems? If so, you may be interested in this clinical research study.
The primary objective is to compare the investigational medication to placebo in order to reduce the occurrence of heart problems when added to the glucose-lowering regimen of patients with type 2 diabetes.
The primary objective is to compare the investigational medication to placebo in order to reduce the occurrence of heart problems when added to the glucose-lowering regimen of patients with type 2 diabetes.
Study Information:
- Study lasts about 5 - 6.5 years, involves up to 19 office visits
- Study-related costs included (laboratory tests, study visits, etc.)
- Compensation for time and travel
If you or someone you know may be interested in this study, please Contact Us to learn more information.
Do you have high triglycerides? Are you at least 18 years of age? If so, you may be interested in this clinical research study.
The primary objective is to evaluate an investigational medication compared to placebo (an inactive substance) in patients at risk for high triglycerides.
The primary objective is to evaluate an investigational medication compared to placebo (an inactive substance) in patients at risk for high triglycerides.
Study Information:
- Study lasts about 12-24 weeks and involves up to 11 visits to site
- Study-related costs included (laboratory tests, study visits, etc.)
- Compensation for time and travel up to about $570.00
If you or someone you know may be interested in this study, please Contact Us to learn more information.